Drug General Information
Drug ID
D0YE2Z
Former ID
DNC011084
Drug Name
(S)-enastron
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531008]
Structure
Download
2D MOL

3D MOL

Formula
C14H14N2O2S
Canonical SMILES
C1CC2=C(C(NC(=S)N2)C3=CC(=CC=C3)O)C(=O)C1
InChI
1S/C14H14N2O2S/c17-9-4-1-3-8(7-9)13-12-10(15-14(19)16-13)5-2-6-11(12)18/h1,3-4,7,13,17H,2,5-6H2,(H2,15,16,19)/t13-/m0/s1
InChIKey
BJTGVSGWTIUCSM-ZDUSSCGKSA-N
PubChem Compound ID
Target and Pathway
Target(s) mRNA of kinesin spindle protein Target Info Inhibitor [531008]
Reactome MHC class II antigen presentation
Kinesins
WikiPathways MHC class II antigen presentation
Kinesins
References
Ref 531008J Med Chem. 2010 Aug 12;53(15):5676-83.Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
Ref 531008J Med Chem. 2010 Aug 12;53(15):5676-83.Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.